These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31257184)

  • 21. Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
    Al-Khafaji AS; Davies MP; Risk JM; Marcus MW; Koffa M; Gosney JR; Shaw RJ; Field JK; Liloglou T
    Br J Cancer; 2017 Feb; 116(5):592-599. PubMed ID: 28095398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.
    Lim H; He D; Qiu Y; Krawczuk P; Sun X; Xie L
    PLoS Comput Biol; 2019 Jun; 15(6):e1006619. PubMed ID: 31206508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting polypharmacology for drug target deconvolution.
    Gujral TS; Peshkin L; Kirschner MW
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):5048-53. PubMed ID: 24707051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
    Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
    Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
    Miljković F; Bajorath J
    J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity.
    Wang X; Huang Y; Christie A; Bowden M; Lee GS; Kantoff PW; Sweeney CJ
    Clin Cancer Res; 2015 Dec; 21(24):5578-87. PubMed ID: 26289068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cabozantinib: Multi-kinase Inhibitor of MET, AXL, RET, and VEGFR2.
    Grüllich C
    Recent Results Cancer Res; 2018; 211():67-75. PubMed ID: 30069760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.
    Du Y; Yamaguchi H; Wei Y; Hsu JL; Wang HL; Hsu YH; Lin WC; Yu WH; Leonard PG; Lee GR; Chen MK; Nakai K; Hsu MC; Chen CT; Sun Y; Wu Y; Chang WC; Huang WC; Liu CL; Chang YC; Chen CH; Park M; Jones P; Hortobagyi GN; Hung MC
    Nat Med; 2016 Feb; 22(2):194-201. PubMed ID: 26779812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics.
    Gridling M; Ficarro SB; Breitwieser FP; Song L; Parapatics K; Colinge J; Haura EB; Marto JA; Superti-Furga G; Bennett KL; Rix U
    Mol Cancer Ther; 2014 Nov; 13(11):2751-62. PubMed ID: 25189542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.
    Otte A; Yang Y; von der Ohe J; Melzer C; Hillemanns P; Feuerhake F; Hass R
    Int J Oncol; 2016 Dec; 49(6):2453-2463. PubMed ID: 27748897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
    Goltsov AA; Fang B; Pandita TK; Maru DM; Swisher SG; Hofstetter WL
    Ann Thorac Surg; 2018 Feb; 105(2):363-370. PubMed ID: 29223420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
    Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
    Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.
    Al-Ali H; Lee DH; Danzi MC; Nassif H; Gautam P; Wennerberg K; Zuercher B; Drewry DH; Lee JK; Lemmon VP; Bixby JL
    ACS Chem Biol; 2015 Aug; 10(8):1939-51. PubMed ID: 26056718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
    Ko JC; Ciou SC; Cheng CM; Wang LH; Hong JH; Jheng MY; Ling ST; Lin YW
    Carcinogenesis; 2008 Jul; 29(7):1448-58. PubMed ID: 18544565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foretinib Overcomes Entrectinib Resistance Associated with the
    Nishiyama A; Yamada T; Kita K; Wang R; Arai S; Fukuda K; Tanimoto A; Takeuchi S; Tange S; Tajima A; Furuya N; Kinoshita T; Yano S
    Clin Cancer Res; 2018 May; 24(10):2357-2369. PubMed ID: 29463555
    [No Abstract]   [Full Text] [Related]  

  • 36. Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
    Ciceri P; Müller S; O'Mahony A; Fedorov O; Filippakopoulos P; Hunt JP; Lasater EA; Pallares G; Picaud S; Wells C; Martin S; Wodicka LM; Shah NP; Treiber DK; Knapp S
    Nat Chem Biol; 2014 Apr; 10(4):305-12. PubMed ID: 24584101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
    Martinelli E; Troiani T; Morgillo F; Rodolico G; Vitagliano D; Morelli MP; Tuccillo C; Vecchione L; Capasso A; Orditura M; De Vita F; Eckhardt SG; Santoro M; Berrino L; Ciardiello F
    Clin Cancer Res; 2010 Oct; 16(20):4990-5001. PubMed ID: 20810384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity to aurora kinase inhibitors in cells resistant against platinum- containing anticancer agents.
    Akiyama M; Izumi H; Wang KY; Yamaguchi T; Kuma A; Kitamura N; Harada Y; Oya R; Yamaguchi K; Iwai Y; Kohno K
    Anticancer Agents Med Chem; 2014; 14(7):1042-50. PubMed ID: 24521151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia.
    Qi J; Gao X; Zhong X; Zhang N; Wang R; Zhang H; Pan T; Liu X; Yao Y; Wu Q; Niu M; Xu K
    Biomed Pharmacother; 2019 Sep; 117():109113. PubMed ID: 31207577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.